Nanobots Therapeutics is a deeptech company focused on developing and commercializing MotionTx platform.

MotionTx technology enables the development of unique therapeutic entities that penetrate tissues with superior efficacy, enhancing drug accumulation in target cells.  

The company is a spin-off of ICREA and IBEC and is the result of the research led by Prof. Samuel Sánchez.